ARTICLE

Design, Synthesis and Molecular Docking Study of 6,7-Dioxo-4-aryl-aminocoumarin

  • Wang Ailing ,
  • Tao Bo ,
  • Ai Chunzhi ,
  • Zheng Xuefang
Expand
  • a College of Agronomy, Northeast Agricultural University, Harbin 150030;
    b Liaoning Key Laboratory of Bio-organic Chemistry, Dalian University, Dalian 116622;
    c Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023

Received date: 2014-11-03

  Revised date: 2014-11-28

  Online published: 2014-12-23

Supported by

Project supported by the National Natural Science Foundation of China (No. 21271036).

Abstract

Catechol-O-methyltransferase (COMT) inhibitors play an important role in the treatment of Parkinson's disease (PD). On the basis of the structure-activity relation (SAR) analysis of existing COMT inhibitors, entacapone and tolcapone, it has been derived that coumarin compounds containing catechol structures may have inhibitory bioactivities on COMT. Thus, the novel COMT inhibitors, 6,7-dioxo-4-arylaminocoumarin compounds, were designed, and their inhibitory bioactivities on COMT were investigated by theoretical calculation. The results show that ten 6,7-dioxo-4-aryl-aminocoumarin compounds exhibit good docking effect, especially 6,7-bis(2-methoxyethoxy)-4-phenylamino-2H-chromen-2-one (6b4) and 4-(3-ethynyl- phenyl)amino-6,7-bis(2-methoxyethoxy)-2H-chromen-2-one (6b5) which have the structure of catechol protected by methoxy ethyl group.

Cite this article

Wang Ailing , Tao Bo , Ai Chunzhi , Zheng Xuefang . Design, Synthesis and Molecular Docking Study of 6,7-Dioxo-4-aryl-aminocoumarin[J]. Chinese Journal of Organic Chemistry, 2015 , 35(4) : 843 -850 . DOI: 10.6023/cjoc201411004

References

[1] Wood-Kaczmar, A.; Gandhi, S.; Wood, N. W. Trends Mol. Med. 2006, 12, 521.
[2] Karhunen, T.; Tilgmann, C.; Ulmanen, I.; Julkunen, I.; Panula, P. Histochem. J. Cytochem. 1994, 42, 1079.
[3] Hegazi, M. F.; Borchard, R. T.; Schowen, R. L. J. Am. Chem. Soc. 1976, 98, 3048.
[4] Diamond, S. G.; Markham, C. H.; Treciokas, L. Ann. Neurol. 1978, 3, 267.
[5] Bartholini, G.; Pletscher, A. Pharmacol. Ther. 1975, 1, 407.
[6] Bonifácio, M. J.; Sutcliffe, J. S.; Torrão, L.; Wright, L. C.; Soares-da-Silva, P. Neuropharmacology 2014, 77, 334.
[7] Learmonth, D. A.; Bonifacio, M. J.; Soares-da-Silva, P. J. Med. Chem. 2005, 48, 8070.
[8] Schrag, A. L. Neurology 2005, 4, 366.
[9] Learmonth, D. A.; Palma, P. N.; Vieira-Coelho, M. A.; Soares-da-Silva, P. J. Med. Chem. 2004, 47, 6207.
[10] Chen, D.; Wang, C. Y.; Lambert, J. D.; Ai, N.; Welsh, W. J.; Yang, C. S. Biochem. Pharmacol. 2005, 69, 1523.
[11] Backstrom, R.; Honkanen, E.; Pippuri, A.; Kairisalo, P.; Pystynen, J.; Heinola, K.; Nissinen, E.; Linden, I. B.; Mannisto, P. T.; Kaakkola, S.; Pohto, P. J. Med. Chem. 1989, 32, 841.
[12] Vladimir, G. Z.; Oenrich, I. P.; Pyodor, A. T. Tetrahedron 1994, 21, 6377.
[13] Zhang, T.; Zheng, Y.; Li, Y. F.; Wang, N. Chin. Chem. Lett. 2013, 24, 719.
[14] Backstrom, R.; Honkanen, E.; Pippuri, A.; Kairisalo, P.; Pystynen, J.; Heinola, K.; Nissinen, E.; Linden, I. B.; Mannisto, P. T.; Kaakkola, S.; Pohto, P. J. Med. Chem., 1989, 32, 841.
[15] Borgulya, J.; Bruderer, H.; Bernauer, K.; Zrcher, G.; Da-Prada, M. Helv. Chim. Acta 1989, 72, 952.
[16] Waldmeier, P. C.; Herdt, P. D.; Maitre. L. J. Neural Transm. Suppl. 1990, 32, 381.
[17] Ai, C. Z.; Wang, Y. H.; Li, Y.; Li, Y. H.; Yang, L. QSAR Comb. Sci. 2008, 27, 1183.
[18] Almeida, L.; Rocha, J. F.; Falcão, A.; Palma, P. N.; Loureiro, A. I.; Pinto, R.; Bonifácio, M. J.; Wright, L. C.; Nunes, T.; Soares-da- Silva, P. Clin Pharmacokinet. 2013, 52, 139.
[19] Theodoros, S. S.; Konstantinos, E. L. Tetrahedron Lett. 2013, 54, 6517.
[20] Dasa, D. K.; Sarkara, S.; Khanc, K.; Belala, M.; Khan, A. T. Tetrahedron Lett. 2014, 55, 4869.
[21] Tsuji, E.; Okazaki, K.; Takeda, K. Biochem. Biophys. Res. Commun. 2009, 378, 494.
[22] Daly, J. W.; Benigni, J.; Minnis, R.; Kanaoka, R.; Witkop, B. Biochemistry 1965, 4, 2513.
[23] Sheng, R.; Lin, X.; Zhang, J.; Chol, K. S.; Huang, W. H.; Yang, B.; He, Q. J.; Hu, Y. Z. Bioorg. Med. Chem. 2009, 18, 6692.
[24] Jones, G. H.; Mackenzie, J. B. D.; Bertsonan, A.; Whalley, W. B. J. Chem. Soc. 1949, 562.
[25] Xiao, D.; Martini, L. A.; Snoeberger, R. C.; III; Crabtree, R. C.; Batista, V. S. J. Am. Chem. Soc. 2011, 133, 9014.
[26] Braccio, M. D.; Grossi, G.; Roma, G.; Marzano, C.; Baccichetti, F.; Simonato, M.; Bordin, F. Farmaco 2003, 58, 1083.
[27] Kuroda, J.; Inamoto, K.; Hiroya, K.; Doi, T. Eur. J. Org Chem. 2009, 19, 2251.
[28] Zhang, L.; Meng, T. H.; Fan, R. H.; Wu, J. J. Org. Chem. 2007, 72, 7279.

Outlines

/